We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Artificial Oxygenator Aids Critical Cardiopulmonary Care

By HospiMedica International staff writers
Posted on 29 Mar 2016
An innovative extracorporeal life support (ECLS) device acts as an intravenous lung, infusing oxygen and removing carbon dioxide (CO2) from the blood. More...


The CardiacAssist TandemLung Oxygenator (TLO) is an intravenous oxygenator (IVOX), an injection-molded device with a radial flow design that contains a bundle of polymethylpentene (PMP) hollow fiber membranes, in which blood is oxygenated and decarbonated. Gases, primarily oxygen, are supplied to interior lumens of the fibers, diffusing from the fiber wall to blood plasma to transfer oxygen to patients requiring urgent cardiac or respiratory support. At the same time, CO2 diffuses from the blood into the inner lumen of the fibers and is exhausted.

A two-part polyurethane compound mechanically fixes the end of the hollow fiber membranes in place, creating a barrier between blood and gas pathways within the TLO. The device is designed to be paired with the TandemHeart blood pump, with a low priming volume protecting patients from the negative effects of diminished cardiac or respiratory function. The CardiacAssist TandemLung Oxygenator and TandemHeart blood pump are products of CardiacAssist (Pittsburgh, PA, USA), and are intended for use in adult patients in need of ECLS during cardiopulmonary bypass procedures for a period of up to six hours.

“After our original TandemHeart pump was cleared for use with an oxygenator in 2011, our team immediately began working with experts in the field to understand how to reduce the complexity of cardiopulmonary bypass technology so that more patients could receive this potentially life-saving procedure,” said John Marous, President and CEO of CardiacAssist. “The design of the TandemLung is a direct result of those efforts.”

ECLS is a variation of cardiopulmonary bypass, but while cardiopulmonary bypass facilitates open heart surgery for a number of hours, ECSL can maintain tissue oxygenation for weeks. As the technology advances, support functions other than gas exchange, such as liver, renal, and cardiac support, could also be provided by ECLS. Further improvements will allow application of ECLS to populations currently excluded from such support, such as those in need of systemic anticoagulation.

Related Links:

CardiacAssist



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Tourniquet System
heidi– mein Tourniquet
New
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.